Gilead Sciences

The Importance of Self Advocacy in Breast Cancer: Janelle's Story

Blog

Janelle Goins was watching TV one evening when she discovered a small nodule in one of her breasts. But she didn’t feel overly concerned because she’s had cysts in the past.

“I thought to myself, it’s just another cyst, and it’s perfect timing because I’m already scheduled to go in for my 40-year-old mammogram,” recalls Janelle, who is Gilead’s Director of Medical Affairs for Patient Engagement.

India's Efforts to Help End Hepatitis C Starts With Prison Population

Blog

A global nonprofit is leading an effort to help eliminate the hepatitis C virus (HCV) among people who are incarcerated in India. Over the last two years, the Foundation for Innovative New Diagnostics (FIND) has been targeting the highly vulnerable group of prison inmates in the northern states of Punjab and Haryana where HCV is particularly prevalent.

“By eliminating the virus in prisons, you can prevent transmission within both the prisons and the general population and ultimately slow the spread of the virus,” explains Sanjay Sarin, Vice President of Access at FIND.

Gilead Sciences Commits to Electrifying Its Fleet

Multimedia with summary

We’re pleased to have joined the Climate Group’s EV100 and to commit to electrifying our fleet of vehicles by 2030.

Thumbi Ndung'u on Thinking Beyond Lifelong Treatment in HIV

Blog

Forty years into the epidemic, African virologist Thumbi Ndung’u is helping map out a plan to achieve a functional cure of HIV. It’s a daunting challenge, yet he believes the evidence and tools can be there in the future to produce ways to eliminate the lifetime burden of antiretroviral therapy and help control the epidemic.

“I work closely with people living with HIV and they always say they wish for a cure,” he says.

'Inside the Innovation:' Oncology Leaders Discuss Life at Gilead

Blog

Behind Gilead’s life-changing medicines are teams of accomplished, imaginative and dedicated individuals who have committed their careers to helping drive innovation.

A new video series on Gilead’s recently redesigned Careers website, provides an opportunity to peel back the curtain and hear firsthand from some of these employees.

Four Questions With Sade Clacken Joseph: Using Film As a Change Agent

Blog

As a first-generation Caribbean American from the Bronx, filmmaker Sadé Clacken Joseph wants to reframe the conversation about underrepresented groups by sharing their often untold stories.

Putting Faith Into Conversations About HIV in the Southern United States

Blog

Faith leaders in the Southern United States aren’t strangers to the disproportionate impact HIV has on Black communities. They’ve seen the shame and stigma that people living with HIV in their communities can face, and they recognize how these things can drive secrecy, isolation and lack of treatment. And now, they’re using the pulpit in a call for change.

Interns Help Facilitate Breast Cancer Conversations Among Young Black Women

Blog

Taylor McKay, a senior at Florida A&M University, always knew she wanted to become a surgeon. But it wasn’t until she did an internship with TOUCH: The Black Breast Cancer Alliance, that she decided to specialize in breast oncology.

“After learning about the disparities in breast cancer diagnosis and treatment for Black women, it really reinforced in my mind how I could help my community,” she says.

Gilead Launches Pharmaceutical Education Program to Increase Workplace Diversity

Blog

When he began teaching biological science at North Carolina Agricultural and Technical State University 11 years ago, it didn’t take long for Dr. Joseph Graves to notice a shortage of opportunities in pharmaceutical research and development for Black students. While A&T has a strong science program, Joseph says it’s been an ongoing struggle for women and underrepresented populations to enter the scientific workforce, and more specifically, find roles in industry.

Four Questions With Tracey Iraca: Combating Age-Related Disparities in Blood Cancer Treatment

Blog

Myelodysplastic syndromes, or MDS, is a rare type of blood cancer primarily affecting people over the age of 65. In fact, it’s such a rare and largely unknown illness that most people living with MDS don’t know anyone else who suffers from it. For Tracey Iraca, Executive Director of the MDS Foundation, a global advocacy organization aimed at providing support and raising awareness of the illness, the most rewarding part of her job is bringing people with MDS together and watching them connect over their shared experiences.

Pages

Subscribe to Gilead Sciences